Literature DB >> 10573382

Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis.

E G de la Concha1, M Fernandez-Arquero, A Martinez, P Vigil, F Vidal, G Lopez-Nava, M Diaz-Rubio, J Garcia-Paredes.   

Abstract

The association of ulcerative colitis with distinct HLA-DRB1 alleles has not been easy to ascertain. Recent studies show that among HLA-DR2 alleles, DRB1*15 but not DRB1*16, is associated with the disease. Similarly, in the HLA-DR1 group, only DRB1*0103 is increased in ulcerative colitis patients. The aim of our study was to identify critical DRB1 residues that might account for these differences. We typed 121 patients with ulcerative colitis and 275 controls using gene amplification and sequence-specific oligonucleotide probing for HLA-DRB1 and DRB3. We observed a strong negative association between HLA-DRB1 alleles that encode lysine at position 71 in their beta-chain and susceptibility to ulcerative colitis. Differences in the prevalence among other alleles differing only in the third hypervariable region suggested a hierarchy of susceptible and protective class II alleles related to the presence of an acidic, neutral, or basic amino acid residue at position 71. These data implicate most strongly the amino acid residues in the third hypervariable region of the DRbeta chain, especially DRbeta71, in the association between ulcerative colitis and HLA. However, this does not exclude the contribution of other parts of the molecule and other immunoregulatory genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573382     DOI: 10.1023/a:1026629409481

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

Review 1.  The molecular basis of susceptibility to rheumatoid arthritis.

Authors:  R Winchester
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

Review 2.  HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases.

Authors:  D Ou; L A Mitchell; A J Tingle
Journal:  J Rheumatol       Date:  1997-02       Impact factor: 4.666

Review 3.  Susceptibility to type I diabetes: HLA-DQ and DR revisited.

Authors:  J X She
Journal:  Immunol Today       Date:  1996-07

4.  Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis.

Authors:  M D Strettell; P T Donaldson; L J Thomson; P J Santrach; S B Moore; A J Czaja; R Williams
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

5.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

6.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

7.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.

Authors:  J Hammer; F Gallazzi; E Bono; R W Karr; J Guenot; P Valsasnini; Z A Nagy; F Sinigaglia
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

8.  Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype.

Authors:  D Ou; L A Mitchell; D Décarie; A J Tingle; G T Nepom
Journal:  Hum Immunol       Date:  1998-03       Impact factor: 2.850

9.  Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?

Authors:  D Heresbach; M Alizadeh; D Reumaux; J F Colombel; M Delamaire; P M Danze; M Gosselin; B Genetet; J F Bretagne; G Semana
Journal:  J Autoimmun       Date:  1996-12       Impact factor: 7.094

10.  HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene.

Authors:  Y C Kong; L C Lomo; R W Motte; A A Giraldo; J Baisch; G Strauss; G J Hämmerling; C S David
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 2.  Genetics of inflammatory bowel disease: the role of the HLA complex.

Authors:  Tariq Ahmad; Sara-E Marshall; Derek Jewell
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  CD209 in inflammatory bowel disease: a case-control study in the Spanish population.

Authors:  Concepción Núñez; Javier Oliver; Juan Luis Mendoza; María Gómez-García; Carlos Taxonera; Luis M Gómez; Miguel A López-Nevot; Emilio G de la Concha; Elena Urcelay; Alfonso Martínez; Javier Martín
Journal:  BMC Med Genet       Date:  2007-12-10       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.